Document Detail


Effects of Dan-Shao-Hua-Xian on the expression of collagen type I and III in rats with hepatic fibrosis.
MedLine Citation:
PMID:  15567745     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Hepatic fibrosis is the common pathological change in various chronic liver diseases, and its major cause is the imbalance between the production and degradation of the extracellular matrix, which is mainly composed of collagens. Dan-Shao-Hua-Xian (DSHX) capsule, a traditional Chinese herbal compound, has shown marked preventive effects on hepatic fibrosis in rats in our previous studies. The present study was designed to further investigate its therapeutic actions on hepatic fibrosis in rats and its possible mechanisms. METHODS: Eighty male Wistar rats were randomly divided into normal control group, hepatic fibrosis group, non-DSHX-treated group, low-dose-treated group, and high-dose-treated group. The rat models of hepatic fibrosis were established by subcutaneous injecton of CCl4, drinking alcohol, giving diet of hyperliprosis and hypoprotein for 8 weeks. The two DSHX-treated groups were treated respectively with low dose (0.5 g/kg) and high dose (1.0 g/kg) of DSHX capsule p.o. everyday for 8 weeks. At the end of the experiment, liver indexes were calculated in each group in addition to the levels of the serum hyaluronic acid and alanine aminotransferase. Their degree of hepatic fibrosis and urinary excretion of hydroxyproline and expression of collagen I, III were detected. RESULTS: Comparison of the indexes of the hepatic fibrosis group and non-DSHX-treated group revealed that the liver indexes, levels of serum hyaluronic acid and alanine aminotransferase, and stage of hepatic fibrosis were all significantly reduced in the two DSHX treated groups. The urinary excretion of hydroxyproline was increased and the expression of collagen I and III in liver tissue was lessened. These alterations were more obviously observed in the high-dose-treated group. CONCLUSION: DSHX capsule has certain therapeutic effect on hepatic fibrosis in rats.
Authors:
Xiao-Xia Geng; Qin Yang; Ru-Jia Xie; Xin-Hua Luo; Cheng-Xiu Li; Ming-Liang Cheng
Related Documents :
10442105 - Experimental cirrhosis of the liver and cytoprotective effects of alpha tocopherol.
16835875 - Gallic acid is partially responsible for the antiangiogenic activities of rubus leaf ex...
18853805 - Treatability of u.s. environmental protection agency contaminant candidate list viruses...
18313245 - Protective effects of total flavonoids of bidens pilosa l. (tfb) on animal liver injury...
1772335 - Guanabenz action on renal excretory function in new zealand genetically hypertensive rats.
1978215 - Intrathecal somatostatin produces effects dependent on the interval between catheter im...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hepatobiliary & pancreatic diseases international : HBPD INT     Volume:  3     ISSN:  1499-3872     ISO Abbreviation:  HBPD INT     Publication Date:  2004 Nov 
Date Detail:
Created Date:  2004-11-29     Completed Date:  2005-04-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101151457     Medline TA:  Hepatobiliary Pancreat Dis Int     Country:  China    
Other Details:
Languages:  eng     Pagination:  558-63     Citation Subset:  IM    
Affiliation:
Department of Infectious Diseases, Affiliated Hospital of Guiyang Medical College, Guizhou 550004, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alanine Transaminase / blood
Animals
Collagen Type I / metabolism*
Collagen Type III / metabolism*
Drugs, Chinese Herbal / pharmacology*
Hyaluronic Acid / blood
Hydroxyproline / urine
Liver / pathology
Liver Cirrhosis / blood,  metabolism*,  pathology,  urine
Male
Medicine, Chinese Traditional*
Organ Size / drug effects
Rats
Rats, Wistar
Chemical
Reg. No./Substance:
0/Collagen Type I; 0/Collagen Type III; 0/Drugs, Chinese Herbal; 0/dan-shao-hua-xian; 51-35-4/Hydroxyproline; 9004-61-9/Hyaluronic Acid; EC 2.6.1.2/Alanine Transaminase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibitory effects of antisense oligodeoxynucleotide on expression of vascular endothelia growth fac...
Next Document:  Abnormal expression of hepatoma-derived gamma-glutamyltransferase subtyping and its early alteration...